Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study).
Casas Deza D, Julián Gomara AB, Caudevilla Biota E, Beltrán B, Domènech E, Gutiérrez Casbas A, Mañosa M, Zabana Y, Roc Alfaro L, Valverde Romero E, García González E, Sicilia B, Laredo V, Alcalá Escriche MJ, Madero Velázquez L, Ferreiro-Iglesias R, Palmero Pérez A, Calafat M, Rubio Iturria S, Moraleja Yudego I, Ber Nieto Y, García Mateo S, Gisbert JP, Vicente Lidón R, Arias L, Alfambra E, Doñate Borao AB, Peña González E, Corsino Roche P, Vicuña Arregui M, Elorza A, Domínguez Cajal M, Chaparro M, Barreiro-de Acosta M, García-López S. Casas Deza D, et al. Among authors: roc alfaro l. Gastroenterol Hepatol. 2024 Aug-Sep;47(7):750-758. doi: 10.1016/j.gastrohep.2023.12.012. Epub 2024 Jan 12. Gastroenterol Hepatol. 2024. PMID: 38219960 English, Spanish.
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).
Casas Deza D, Julián Gomara AB, Caudevilla Biota E, Beltrán B, Domènech E, Gutiérrez Casbas A, Mañosa M, Zabana Y, Roc Alfaro L, Valverde Romero E, García González E, Sicilia B, Laredo V, Alcalá Escriche MJ, Madero Velázquez L, Ferreiro-Iglesias R, Palmero Pérez A, Calafat M, Rubio Iturria S, Moraleja Yudego I, Ber Nieto Y, García Mateo S, Gisbert JP, Vicente Lidón R, Arias L, Alfambra E, Doñate Borao AB, Peña González E, Corsino Roche P, Vicuña Arregui M, Elorza A, Domínguez Cajal M, Chaparro M, Barreiro-de Acosta M, García-López S. Casas Deza D, et al. Among authors: roc alfaro l. Gastroenterol Hepatol. 2024 Oct;47(8):821-833. doi: 10.1016/j.gastrohep.2023.11.004. Epub 2023 Nov 23. Gastroenterol Hepatol. 2024. PMID: 38007154 English, Spanish.
[The incidence of lues in a Zaragoza hospital over a period of 13 years].
Báez López N, Palacián Ruiz MP, Vásquez Martínez A, Roc Alfaro L. Báez López N, et al. Among authors: roc alfaro l. Gac Sanit. 2013 Nov-Dec;27(6):564-5. doi: 10.1016/j.gaceta.2013.03.003. Epub 2013 May 3. Gac Sanit. 2013. PMID: 23643718 Free article. Spanish. No abstract available.
[Amoebic liver abscess].
Palacián Ruiz P, Monforte Cirac ML, Roc Alfaro L, Lomba Fuentes E, Bouthelier Moreno M, De Juan Martín F, Revillo Pinilla MJ. Palacián Ruiz P, et al. Among authors: roc alfaro l. An Pediatr (Barc). 2009 Dec;71(6):571-2. doi: 10.1016/j.anpedi.2009.07.035. Epub 2009 Oct 28. An Pediatr (Barc). 2009. PMID: 19875345 Free article. Spanish. No abstract available.
[Severe toxoplasmosis: two case reports].
Jiménez Hereza JM, Jiménez Montañés L, Rebage Moisés V, Roc Alfaro L, Edo Gimeno MJ, Elizalde Usechi M, Ferrer Novellas C, Marco Tello A. Jiménez Hereza JM, et al. Among authors: roc alfaro l. An Esp Pediatr. 1996 Oct;45(4):425-7. An Esp Pediatr. 1996. PMID: 9005734 Spanish. No abstract available.